BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
578 results:

  • 1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Novel Anti-tumor Strategy for breast cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cells.
    Yılmaz G; Özdemir F
    Anticancer Agents Med Chem; 2024; 24(3):224-234. PubMed ID: 38629155
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PGR-kitLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.
    Yang Z; Chen H; Yin S; Mo H; Chai F; Luo P; Li Y; Ma L; Yi Z; Sun Y; Chen Y; Wu J; Wang W; Yin T; Zhu J; Shi C; Zhang F
    Cancer Lett; 2024 May; 589():216795. PubMed ID: 38556106
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
    He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
    J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer.
    Zhong X; Ke X; Yang H; Ye X; Li C; Pan J; Ran W; Wang F; Cui H
    Phytomedicine; 2024 Jun; 128():155527. PubMed ID: 38489888
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.
    Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W
    Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced breast cancer Receiving Palbociclib: Results From the TREnd Trial.
    Migliaccio I; Romagnoli D; Galardi F; De Luca F; Biagioni C; Curigliano G; Criscitiello C; Minisini AM; Moretti E; Risi E; Guarducci C; Nardone A; Biganzoli L; Benelli M; Malorni L
    JCO Precis Oncol; 2024 Feb; 8():e2300285. PubMed ID: 38427931
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genistin Represses the Proliferation and Angiogenesis While Accelerating the Apoptosis of Glioma Cells by Modulating the FOXC1-Mediated Wnt Signaling Pathway.
    Lan X; Gui Z; Chen T; Tang M; Wang H
    Discov Med; 2024 Feb; 36(181):332-342. PubMed ID: 38409838
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis.
    Chen Z; Lu P; Li M; Zhang Q; He T; Gan L
    Medicine (Baltimore); 2024 Feb; 103(8):e37264. PubMed ID: 38394486
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ZSWIM4 inhibition improves chemosensitivity in epithelial ovarian cancer cells by suppressing intracellular glycine biosynthesis.
    Gong K; Huang Y; Zheng Y; Hao W; Shi K
    J Transl Med; 2024 Feb; 22(1):192. PubMed ID: 38383406
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial.
    Zhang M; Zhang G; Niu Y; Zhang G; Ji Y; Yan X; Zhang X; Wang Q; Jing X; Wang J; Ma Z; Wang H
    Nat Commun; 2024 Feb; 15(1):1512. PubMed ID: 38374204
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multiplex Assay of Cytokines with Tunable Detection Ranges for the Precise Diagnosis of breast cancer.
    Shi H; Zeng T; Liang Q; Yang J; Chen R; Wu S; Duan N; Zhao J; Li G; Yin Y
    Anal Chem; 2024 Feb; 96(8):3662-3671. PubMed ID: 38363802
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Formulation of patient dose of [
    Amirdhanayagam J; Guleria M; Sharma R; Kumar N; Mukherjee A; Das T
    J Labelled Comp Radiopharm; 2024 Apr; 67(4):131-144. PubMed ID: 38342496
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Investigation of the effect of belinostat on MCF-7 breast cancer stem cells via the Wnt, Notch, and Hedgehog signaling pathway.
    Tuncer Z; Kurar E; Duran T
    Saudi Med J; 2024 Feb; 45(2):121-127. PubMed ID: 38309728
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation.
    Wang R; Gao Y; Wen S; Guo X
    BMC Med Genomics; 2024 Feb; 17(1):45. PubMed ID: 38302910
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Paris saponin VII promotes ferroptosis to inhibit breast cancer via Nrf2/GPX4 axis.
    Yan C; Xuan F
    Biochem Biophys Res Commun; 2024 Feb; 697():149524. PubMed ID: 38252991
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Synthesis and Preliminary Study of
    Ma M; Yang G; Zhao M; Liu Y; Ge X; Jia B; Gao S
    Mol Pharm; 2024 Feb; 21(2):735-744. PubMed ID: 38193393
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tamoxifen induces ferroptosis in MCF-7 organoid.
    Ye L; Zhong F; Sun S; Ou X; Yuan J; Zhu J; Zeng Z
    J Cancer Res Ther; 2023 Dec; 19(6):1627-1635. PubMed ID: 38156931
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. SLC35A2 expression drives breast cancer progression via ERK pathway activation.
    Yang X; Tao Y; Xu Y; Cai W; Shao Q
    FEBS J; 2024 Apr; 291(7):1483-1505. PubMed ID: 38143314
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.